Sort
51,570 grants matching “autoimmune disease”
Development of Drugs Acting at Adenosine Receptors
$745,815Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Immunopathogenesis of Fungal Infections
$745,599Michail Lionakis · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Islet-specific CD8 T cells in the pathogenesis of type 1 diabetes
$745,583Maki Nakayama · University Of Colorado Denver · R01 · FY2025 · DK
Genomics of NFκB-mediated gene regulation in multiple sclerosis
$745,457Chris Cotsapas · Yale University · R01 · FY2016 · AI
Micro-nanotechnologies for the analysis of islet-derived extracellular vesicles implicated in Type 1 Diabetes
$745,410Alphonsus Ng · University Of Utah · R01 · FY2022 · DK
Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function
$745,302Jennifer K Hoffman · Duke University · R01 · FY2025 · AI
Structure, Function and Mechanistic Analysis of LAG3
$745,225Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
PTPN22 R619W in NOD mice
$745,163Linda A Sherman · Scripps Research Institute, The · U01 · FY2020 · AI
PTPN22 R619W in NOD mice
$745,163Linda A Sherman · Scripps Research Institute, The · U01 · FY2021 · AI
PTPN22 R619W in NOD mice
$745,163Linda A Sherman · Scripps Research Institute, The · U01 · FY2019 · AI
PTPN22 R619W in NOD mice
$745,163Linda A Sherman · Scripps Research Institute, The · U01 · FY2018 · AI
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
$745,000Brenda L. Bass · University Of Utah · DP1 · FY2015 · AG
Cellular double-stranded RNA as a signal of stress, immunity, and aging.
$745,000Brenda L. Bass · University Of Utah · DP1 · FY2014 · AG
Washington University Rheumatic DiseasesResearch Resource-based Center
$744,893Christine T Pham · Washington University · P30 · FY2022 · AR
Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression
$744,857Shuibing Chen · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DK
UCSF Trialnet: A Phase II Trial of Imatimib in New Onset Type I Diabetes
$744,830Stephen E Gitelman · University Of California, San Francisco · U01 · FY2011 · DK
Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes
$744,819Wei-Jun Qian · Battelle Pacific Northwest Laboratories · R01 · FY2020 · DK
Translational Vascular Biology in Autoimmune Diseases
$744,615Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P30 · FY2010 · AR
Improving Minority Health in Rheumatic Diseases
$744,614Gary S. Gilkeson · Medical University Of South Carolina · P30 · FY2017 · AR
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2023 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2024 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2022 · AG
Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype
$744,449Elena Myasoedova · Mayo Clinic Rochester · R01 · FY2021 · AG
Immune reconstitution following autologous and allogeneic stem cell transplant
$744,123Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Spatiotemporal Health Analytics: Geospatial connections to toxicology
$744,119Kyle Messier · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES